Clomipramine hydrochloride
Clomipramine hydrochloride: 1 brand, 21 generics; first approved Dec 29, 1989; generic available.
Generic available: 21 ANDA applications approved.
Brand (NDA) products
- SPECGX LLCNDA 01990619893 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Rx AB 50MG CAPSULE ORAL Rx AB 75MG CAPSULE ORAL Rx AB
Generic (ANDA) products (21)
- CLOMIPRAMINE HYDROCHLORIDEAUROBINDO PHARMAANDA 21644020233 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Rx AB 50MG CAPSULE ORAL Rx AB 75MG CAPSULE ORAL Rx AB - CLOMIPRAMINE HYDROCHLORIDEALEMBICANDA 21182220213 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Rx AB 50MG CAPSULE ORAL Rx AB 75MG CAPSULE ORAL Rx AB - CLOMIPRAMINE HYDROCHLORIDEAJANTA PHARMA LTDANDA 21389720203 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - 50MG CAPSULE ORAL Discontinued - 75MG CAPSULE ORAL Discontinued - - CLOMIPRAMINE HYDROCHLORIDEUNIQUEANDA 21228520203 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Rx AB 50MG CAPSULE ORAL Rx AB 75MG CAPSULE ORAL Rx AB - CLOMIPRAMINE HYDROCHLORIDEMICRO LABSANDA 21321920203 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Rx AB 50MG CAPSULE ORAL Rx AB 75MG CAPSULE ORAL Rx AB - CLOMIPRAMINE HYDROCHLORIDERK PHARMAANDA 21322120203 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - 50MG CAPSULE ORAL Discontinued - 75MG CAPSULE ORAL Discontinued - - CLOMIPRAMINE HYDROCHLORIDETP ANDA HOLDINGSANDA 21065320203 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - 50MG CAPSULE ORAL Discontinued - 75MG CAPSULE ORAL Discontinued - - CLOMIPRAMINE HYDROCHLORIDELEADINGANDA 21136420203 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Rx AB 50MG CAPSULE ORAL Rx AB 75MG CAPSULE ORAL Rx AB - CLOMIPRAMINE HYDROCHLORIDEJUBILANT CADISTAANDA 21221820193 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Rx AB 50MG CAPSULE ORAL Rx AB 75MG CAPSULE ORAL Rx AB - CLOMIPRAMINE HYDROCHLORIDEMANKIND PHARMAANDA 21176720193 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Rx AB 50MG CAPSULE ORAL Rx AB 75MG CAPSULE ORAL Rx AB - CLOMIPRAMINE HYDROCHLORIDELUPINANDA 20929420183 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Rx AB 50MG CAPSULE ORAL Rx AB 75MG CAPSULE ORAL Rx AB - CLOMIPRAMINE HYDROCHLORIDEAMNEAL PHARMS COANDA 20863220183 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - 50MG CAPSULE ORAL Discontinued - 75MG CAPSULE ORAL Discontinued - - CLOMIPRAMINE HYDROCHLORIDEZYDUS PHARMSANDA 20896120173 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Rx AB 50MG CAPSULE ORAL Rx AB 75MG CAPSULE ORAL Rx AB - CLOMIPRAMINE HYDROCHLORIDEWATSON LABSANDA 07475119983 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - 50MG CAPSULE ORAL Discontinued - 75MG CAPSULE ORAL Discontinued - - CLOMIPRAMINE HYDROCHLORIDEPHARMOBEDIENTANDA 07494719983 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - 50MG CAPSULE ORAL Discontinued - 75MG CAPSULE ORAL Discontinued - - CLOMIPRAMINE HYDROCHLORIDETEVAANDA 07495819973 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - 50MG CAPSULE ORAL Discontinued - 75MG CAPSULE ORAL Discontinued - - CLOMIPRAMINE HYDROCHLORIDESANDOZANDA 07495319973 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Rx AB 50MG CAPSULE ORAL Rx AB 75MG CAPSULE ORAL Rx AB - CLOMIPRAMINE HYDROCHLORIDETEVAANDA 07484919973 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - 50MG CAPSULE ORAL Discontinued - 75MG CAPSULE ORAL Discontinued - - CLOMIPRAMINE HYDROCHLORIDETAROANDA 07469419963 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Rx AB 50MG CAPSULE ORAL Rx AB 75MG CAPSULE ORAL Rx AB - CLOMIPRAMINE HYDROCHLORIDEWATSON LABSANDA 07460019963 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - 50MG CAPSULE ORAL Discontinued - 75MG CAPSULE ORAL Discontinued - - CLOMIPRAMINE HYDROCHLORIDECHARTWELL RXANDA 07436419963 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Rx AB 50MG CAPSULE ORAL Rx AB 75MG CAPSULE ORAL Rx AB
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Approval history
Approvals span 1989โ2023 across 22 FDA applications.
Clomipramine hydrochloride: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
Assyro Intelligence
Ask anything about Clomipramine hydrochloride
Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.
Evaluating for a team? Book a demo
